Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01207401 · ClinicalTrials.gov registry record · NA
Paracervical Block Before Intrauterine Device (IUD) Insertion
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT01207401 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 50 participants.
The verdict
NCT01207401, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate if a paracervical block containing 1% lidocaine administered prior to IUD insertion reduces insertion pain. The hypothesis is that women receiving paracervical analgesia will experience less pain during IUD insertion than those who do not receive such analgesia.
Interventions
- DRUG Lidocaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2010-07 |
| Est. Completion | 2011-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01207401
The ClinicalTrials.gov registry entry for NCT01207401 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lidocaine is the first listed.
NCT01207401 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01207401 about?
NCT01207401 is a clinical study titled "Paracervical Block Before Intrauterine Device (IUD) Insertion". The purpose of this study is to evaluate if a paracervical block containing 1% lidocaine administered prior to IUD insertion reduces insertion pain. The hypothesis is that women receiving paracervical analgesia will experience less pain during IUD insertion than those who do not receive such analges...
What is the current status of trial NCT01207401?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2010-07. Estimated completion is 2011-02.
What interventions are being tested in trial NCT01207401?
The interventions under investigation include: Lidocaine (DRUG).
Who is sponsoring clinical trial NCT01207401?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.